Wells Fargo analyst Finian O’Shea raised the firm’s price target on Crescent Capital BDC to $18 from $16.50 and keeps an Equal Weight rating on the shares. Some one-time fee/OID acceleration and stable credit help CCAP put up a solid quarter, the firm says.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCAP:
- Crescent Capital BDC price target raised to $19 from $18 at Raymond James
- Crescent Capital BDC increases quarterly dividend to 42c per share
- Crescent Capital BDC reports Q1 EPS 63c, consensus 58c
- Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
